On January 12, 2026, Chengdu Baiyu Pharmaceutical Co., Ltd. (hereinafter referred to as “Baiyu”) received the GMP Certificate (No. M043/25) issued by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia, indicating that Baiyu's Ginkgolide Injection production line has successfully passed the Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP compliance inspection.

The PIC/S is an internationally recognized authority in pharmaceutical inspection and certification. PIC/S GMP certificates are mutually recognized and shared among more than 50 member countries, and are highly influential worldwide.

This certification demonstrates that Baiyu's manufacturing and quality management systems are in full compliance with PIC/S GMP standards. It will facilitate the drug registration of Ginkgolide Injection in Malaysia and other PIC/S member countries, and provide strong support for the expansion of Baiyu's international business.